1. Home
  2. DRCT vs AFMD Comparison

DRCT vs AFMD Comparison

Compare DRCT & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRCT
  • AFMD
  • Stock Information
  • Founded
  • DRCT 2018
  • AFMD 2000
  • Country
  • DRCT United States
  • AFMD Germany
  • Employees
  • DRCT N/A
  • AFMD N/A
  • Industry
  • DRCT Computer Software: Programming Data Processing
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • DRCT Technology
  • AFMD Health Care
  • Exchange
  • DRCT Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • DRCT 38.7M
  • AFMD 45.6M
  • IPO Year
  • DRCT 2022
  • AFMD 2014
  • Fundamental
  • Price
  • DRCT $0.61
  • AFMD $1.27
  • Analyst Decision
  • DRCT Strong Buy
  • AFMD Strong Buy
  • Analyst Count
  • DRCT 3
  • AFMD 5
  • Target Price
  • DRCT $21.00
  • AFMD $13.50
  • AVG Volume (30 Days)
  • DRCT 197.1K
  • AFMD 502.9K
  • Earning Date
  • DRCT 11-12-2024
  • AFMD 11-14-2024
  • Dividend Yield
  • DRCT N/A
  • AFMD N/A
  • EPS Growth
  • DRCT N/A
  • AFMD N/A
  • EPS
  • DRCT N/A
  • AFMD N/A
  • Revenue
  • DRCT $94,216,000.00
  • AFMD $6,287,085.00
  • Revenue This Year
  • DRCT $17.00
  • AFMD N/A
  • Revenue Next Year
  • DRCT N/A
  • AFMD $28.44
  • P/E Ratio
  • DRCT N/A
  • AFMD N/A
  • Revenue Growth
  • DRCT N/A
  • AFMD N/A
  • 52 Week Low
  • DRCT $0.61
  • AFMD $1.19
  • 52 Week High
  • DRCT $35.88
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • DRCT 26.06
  • AFMD 16.00
  • Support Level
  • DRCT $0.61
  • AFMD $1.40
  • Resistance Level
  • DRCT $1.04
  • AFMD $2.21
  • Average True Range (ATR)
  • DRCT 0.14
  • AFMD 0.24
  • MACD
  • DRCT 0.01
  • AFMD -0.08
  • Stochastic Oscillator
  • DRCT 5.73
  • AFMD 3.33

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: